Molecular profiling of meningiomas can predict treatment response and survival, according to a study in Nature Medicine. Craig Horbinski, MD, PhD, highlights the potential of molecular data to improve clinical outcomes. The study analyzed over 2,800 meningiomas, finding total resection and dural margin treatment beneficial. DNA loss and DNA methylation changes were key determinants of tumor behavior.